RIBAVIRIN DOES NOT IMPACT HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS ON OMBITASVIR/ PARITAPREVIR /RITONAVIR AND DASABUVIR AT THE END OF 12-WEEK TREATMENT IN TREATMENT-NAIVE ADULTS WITH GENOTYPE 1A (GT1A) CHRONIC HEPATITIS C

被引：0
|
作者：
Liu, Y. [1 ]
Bernstein, D. [2 ]
Larsen, L. [1 ]
Luo, Y. [1 ]
Xie, Y. [1 ]
Juday, T. [1 ]
机构：
[1] AbbVie Inc, N Chicago, IL USA
[2] N Shore Univ Hosp, Manhasset, IL USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI30
引用
收藏
页码：A227 / A227
页数：1
相关论文
共 50 条
  • [11] Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis
    Poordad, Fred
    Sedghi, Shahriar
    Pockros, Paul J.
    Ravendhran, Natarajan
    Reindollar, Robert
    Lucey, Michael R.
    Epstein, Michael
    Bank, Leslie
    Bernstein, David
    Trinh, Roger
    Krishnan, Preethi
    Polepally, Akshanth R.
    Unnebrink, Kristina
    Martinez, Marisol
    Nelson, David R.
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (08) : 1027 - 1030
  • [12] COST-EFFECTIVENESS OF OMBITASVIR/PARITAPREVIR/RITONAVIR WITH OR WITHOUT DASABUVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C PATIENTS INFECTED WITH GENOTYPE 1 OR 4 IN FRANCE
    Sroczynski, G.
    Conrads-Frank, A.
    Muhlberger, N.
    Kuhne, F.
    Jeanblanc, G.
    Samp, J. C.
    Durand-Zaleski, I
    Siebert, U.
    VALUE IN HEALTH, 2016, 19 (07) : A416 - A416
  • [13] Health-related quality of life in genotype 1 treatment-naive chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study
    Vera-Llonch, M.
    Martin, M.
    Aggarwal, J.
    Donepudi, M.
    Bayliss, M.
    Goss, T.
    Younossi, Z.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (02) : 124 - 133
  • [14] Paritaprevir/Ritonavir/Ombitasvir plus Dasabuvir regimen in the treatment of genotype 1 chronic hepatitis C infection in kidney transplant candidates.
    Sperl, J.
    Kreidlova, M.
    Senkerikova, R.
    Chmelova, K.
    Merta, D.
    Frankova, S.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 71 - 72
  • [15] Paritaprevir/ritonavir/ombitasvir plus dasabuvir with ribavirin for treatment of recurrent chronic hepatitis C genotype 1 infection after liver transplantation: Real-world experience
    Yu, Ming-Lung
    Chen, Yao-Li
    Huang, Chung-Feng
    Lin, Kuo-Hua
    Yeh, Ming-Lun
    Huang, Ching-I
    Hsieh, Meng-Hsuan
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Huang, Jee-Fu
    Dai, Chia-Yen
    Chuang, Wan-Long
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2018, 117 (06) : 518 - 526
  • [16] A Retrospective Cohort Study: Safety and Effectiveness of Elbasvir/Grazoprevir ± Ribavirin Compared With Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir ± Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection
    Hung, Hsuan-Yu
    Chen, Chung-Yu
    Liao, Yi-Hsiang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [17] Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Ribavirin for Treatment of Hepatitis C Virus Genotype 1: A Systematic Review and Meta-analysis
    Ahmed, Hussien
    Abushouk, Abdelrahman Ibrahim
    Menshawy, Amr
    Mohamed, Arwa
    Negida, Ahmed
    Loutfy, Samah A.
    Abdel-Daim, Mohamed M.
    CLINICAL DRUG INVESTIGATION, 2017, 37 (11) : 1009 - 1023
  • [18] Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Ribavirin for Treatment of Hepatitis C Virus Genotype 1: A Systematic Review and Meta-analysis
    Hussien Ahmed
    Abdelrahman Ibrahim Abushouk
    Amr Menshawy
    Arwa Mohamed
    Ahmed Negida
    Samah A. Loutfy
    Mohamed M. Abdel-Daim
    Clinical Drug Investigation, 2017, 37 : 1009 - 1023
  • [19] Real-life data on the efficacy and safety of ombitasvir/paritaprevir//ritonavir plus dasabuvir plus ribavirin in the patients with genotype 1 chronic hepatitis C virus infection in Serbia
    Babic, Jasmina Simonovic
    Bojovic, Ksenija
    Fabri, Milotka
    Cvejic, Tatjana
    Svorcan, Petar
    Nozic, Darko
    Jovanovic, Maja
    Skrbic, Ranko
    Stojiljkovic, Milos P.
    Mijailovic, Zeljko
    VOJNOSANITETSKI PREGLED, 2019, 76 (05) : 531 - 536
  • [20] Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin Regimen for Patients Infected With Chronic Hepatitis C Virus Genotype 1 in Malaysia
    Shafie, Asrul Akmal
    Abu Hassan, Muhammad Radzi
    Ong, Siew Chin
    Virabhak, Suchin
    Gonzalez, Yuri Sanchez
    VALUE IN HEALTH REGIONAL ISSUES, 2020, 21 : 164 - 171
12345